-
公开(公告)号：US10532124B2
公开(公告)日：2020-01-14
申请号：US14655359
申请日：2012-12-27
Applicant: Kimberly-Clark Worldwide, Inc.
Inventor： David William Koenig , Mary Kay Foegen , Corey Thomas Cunningham , Aimin He , Yang Huang
Abstract: Farnesol analogs, along with their related products (e.g., treatment compositions, wipes, absorbent articles, etc.) and their methods of formation, are provided. The farnesol analog includes a hydrophilic end group (e.g., a hydroxyl end group or a carboxylic acid end group) attached to farnesol via a covalent linkage (e.g., an ester group or an ether group).
-
公开(公告)号：US09826876B2
公开(公告)日：2017-11-28
申请号：US14042071
申请日：2013-09-30
Applicant: Kimberly-Clark Worldwide, Inc.
Inventor： Kaiyuan Yang , Andrew T Baker , Joseph R Feldkamp , David William Koenig , WanDuk Lee , Carl G Rippl , Kathleen C Engelbrecht , Waihong Leong , Dave A Soerens , Divesh Bhatt , Jin Heo , Jose Kollakompil Abraham
Abstract: A cleaning article includes a cleaning article sheet comprising a fabric substrate, wherein the fabric substrate includes pores therein, and wherein the fabric substrate has a background moisture percentage by weight, and liquid water disposed substantially and disconnectedly within the pores, wherein the liquid water is at moisture percentage by weight that is 5 to 150 percentage points higher than the background moisture percentage. The nonwoven substrate can include pores formed between and/or within the fibers and can have a background moisture percentage by weight. The substrate can include a treatment to increase the dielectric constant from the dielectric constant of the substrate without the treatment. The moisture of the article can be configured to exhibit a dielectric constant of at least 50% and up to 600% higher than the dielectric constant of the same article with only background moisture.
-
公开(公告)号：US20220257622A1
公开(公告)日：2022-08-18
申请号：US17738286
申请日：2022-05-06
Applicant: Kimberly-Clark Worldwide, Inc.
Inventor： Jingru Li , Lindsay Adrienne Peed , Cheryce Francina Joyner , Rebecca Ann Vongsa , David William Koenig , Ryan Daniel Bartell
IPC: A61K31/702 , A61K31/7016 , A61K31/719 , A61K31/7004 , A61K31/194 , A61K31/192 , A61K31/19 , A61K31/191 , A61P15/02 , A61K9/00 , A61K47/12
Abstract: The present invention provides compositions and formulations capable of maintaining or promoting the growth of certain strains of Lactobacilli spp. The compositions and formulations generally comprise only a single therapeutic agent selected from the group consisting of isomaltulose, maltitol, pullulan, maltotriose, 2-deoxy-D-ribose, 1-kestose and erlose. The single therapeutic agent is the sole source of carbon for bacterium when administered to a user. Despite comprising only a single therapeutic agent the compositions have been shown to promote the growth and maintenance of beneficial Lactobacilli and to effectively inhibit the growth of pathogens associated with urogenital infections. As such administration of the compositions maintain a healthy microflora balance in the urogenital area.
-
公开(公告)号：US20180207313A1
公开(公告)日：2018-07-26
申请号：US15514694
申请日：2015-04-01
Applicant: KIMBERLY-CLARK WORLDWIDE, INC.
Inventor： Shiming Zhuang , Rebecca Ann Vongsa , Peiguang Zhou , Andrew Mark Long , David William Koenig , David J. Tyrell , Paige N. Anunson
CPC classification number: A61L15/46 , A61F13/00063 , A61F13/15211 , A61F13/8405 , A61F2013/00642 , A61F2013/15235 , A61F2013/530233 , A61L15/225 , A61L15/24 , A61L15/26 , A61L15/28 , A61L15/44 , A61L15/62 , A61L2300/208 , A61L2300/216 , A61L2300/232 , A61L2300/30 , A61L2300/404 , C08K5/0058 , C08L3/02 , C08L29/04 , C08L31/04 , C08L101/14
Abstract: An extruded water-soluble article is made from homogeneous material that includes a water-soluble polymer having an extrusion temperature of 50 to 150° C. This relatively low extrusion temperature is compatible with actives that would otherwise be destroyed in a high temperature extrusion process. The article further includes between 0.1% to 50% by weight of an active agent. Potential active agents include, isothiazolone, alkyl dimethyl ammonium chloride, a triazine, 2-thiocyanomethylthio benzothiazol, methylene bis thiocyanate, acrolein, dodecylguanidine hydrochloride, a chlorophenol, a quaternary ammonium salt, gluteraldehyde, a dithiocarbamate, 2-mercatobenzothiazole, para-chloro-meta-xylenol, silver-based compounds, chlorohexidine, polyhexamthylene biguanide, a n-halamine, triclosan, a phospholipid, an alpha hydroxyl acid, 2,2-dibromo-3-nitrilopropionamide, 2-bromo-2-nitro-1,3-propanediol, iodine, bromine, hydrogen peroxide, chlorine dioxide, ozone, a botanical oil, a botanical extract, chlorine, sodium hypochlorite, farnasol, inulin, prebiotics, benzalkonium chloride, and combinations thereof. The article may be in the form of a film, and in one potential use, be disposed in an absorbent article.
-
公开(公告)号：US20170258823A1
公开(公告)日：2017-09-14
申请号：US15512951
申请日：2014-09-30
Applicant: Kimberly-Clark Worldwide, Inc.
Inventor： David William Koenig , Michael Andrew Zawadzki , Cathleen Mae Uttecht , Jeffrey Janne Johnson , David Andrew Moline , Rebecca Ann Vongsa , Amy Lynn Vanden Heuvel , YoungSook Kim , SangHa Park , Jessica Caroline Rogers
IPC: A61K31/733 , A61K9/70 , A61K47/26 , A61K31/19
CPC classification number: A61K31/733 , A61K9/7007 , A61K31/19 , A61K31/191 , A61K31/194 , A61K31/702 , A61K45/06 , A61K47/26 , A61P1/00 , A61P17/00 , A61P43/00 , A61K2300/00
Abstract: The present invention relates to prebiotic compositions and formulations comprising an α-hydroxy acid and salts thereof, such as lactic, glycolic, citric, tartaric or malic acid and a prebiotic agent, such as inulin, fructo-oligosaccharide (FOS), lactulose, galacto-oligosaccharide (GOS), raffinose, stachyose, isomalto-oligosaccharide, and xylo-oligosaccharide. Prebiotic compositions of the present invention provide a surprisingly synergist prebiotic effect and may be administered in several forms to a user, such as by application to a premoistened wiping substrate or dry bath tissue.
-
Patent Agency Ranking
公开(公告)号：US09744248B2
公开(公告)日：2017-08-29
申请号：US15367331
申请日：2016-12-02
Applicant: Kimberly-Clark Worldwide, Inc.
Inventor： Michael Andrew Zawadzki , Jeffrey Janne Johnson , David William Koenig , Amy Lynn Vanden Heuvel , David Andrew Moline , Rebecca Ann Vongsa , Cathleen Mae Uttecht , Donald Eugene Waldroup
CPC classification number: A61K47/6953 , A61F2/04 , A61F2002/045 , A61K31/19 , A61K31/733 , A61K47/595 , A61L15/42 , A61L15/44 , A61L2300/232 , B31F1/12 , B31F1/126 , D21H21/146 , D21H27/00 , D21H27/002
Abstract: The invention relates to creped prebiotic tissue products. The tissue products comprise prebiotics in sufficiently high amounts to have a prebiotic effect in use, without negatively affecting tissue product properties, such as tensile strength, stiffness or softness. Thus, in certain embodiments the present invention provides soft, durable creped prebiotic tissue products that are able to improve the growth of healthy bacteria such as Bifidobacterium spp. or Lactobacillus spp. without promoting growth of enteropathogenic bacteria. The tissue products provide these benefits yet have a GMT greater than about 500, a Stiffness Index less than about 20 and a TS7 value less than about 10.
-
公开(公告)号：US20160250353A1
公开(公告)日：2016-09-01
申请号：US14766087
申请日：2014-09-30
Applicant: KIMBERLY-CLARK WORLDWIDE, INC.
Inventor： Michael Andrew Zawadzki , Jeffrey Janne Johnson , David William Koenig , Amy Lynn Vanden Heuvel , David Andrew Moline , Rebecca Ann Vongsa , Cathleen Mae Uttecht , Donald Eugene Waldroup
IPC: A61K47/48 , B31F1/12 , A61K31/733
CPC classification number: A61K47/6953 , A61F2/04 , A61F2002/045 , A61K31/19 , A61K31/733 , A61K47/595 , A61L15/42 , A61L15/44 , A61L2300/232 , B31F1/12 , B31F1/126 , D21H21/146 , D21H27/00 , D21H27/002
Abstract: The invention relates to creped prebiotic tissue products. The tissue products comprise prebiotics in sufficiently high amounts to have a prebiotic effect in use, without negatively affecting tissue product properties, such as tensile strength, stiffness or softness. Thus, in certain embodiments the present invention provides soft, durable creped prebiotic tissue products that are able to improve the growth of healthy bacteria such as Bifidobacterium spp. or Lactobacillus spp. without promoting growth of enteropathogenic bacteria. The tissue products provide these benefits yet have a GMT greater than about 500, a Stiffness Index less than about 20 and a TS7 value less than about 10.
Abstract translation: 本发明涉及起皱益生菌组织产品。 组织产品包括足够高量的益生元，以在使用中具有益生元效应，而不会不利地影响组织产品性质，例如拉伸强度，刚度或柔软度。 因此，在某些实施方案中，本发明提供了能够改善健康细菌如双歧杆菌的生长的柔软耐用的起皱益生元组织产品。 或乳杆菌属（Lactobacillus spp。） 不促进肠病毒细菌的生长。 纸巾产品提供了这些好处，但是GMT大于约500，刚度指数小于约20，TS7值小于约10。
-
公开(公告)号：US20130324961A1
公开(公告)日：2013-12-05
申请号：US13962251
申请日：2013-08-08
Applicant: Kimberly-Clark Worldwide, Inc.
Inventor： Jason C. Cohen , Kenneth Thomas Borowski , Rodney Lee Miller, JR. , Martin Joseph Garofalo , David William Koenig , Tatum Marie Jeleno , Eric Donald Johnson
IPC: A61F13/84
CPC classification number: A61F13/84 , A61F13/8405
Abstract: An absorbent article comprises a bodyside liner, an outer cover, an absorbent body located between the bodyside liner and the outer cover, and an enclosure. The enclosure comprises a cover and backing joined together to form a pocket with an object disposed therein. The enclosure is joined with the absorbent article and is adapted to transition from a closed condition to an open condition such that the object disposed within the enclosure may be accessed.
Abstract translation: 吸收制品包括体侧衬里，外罩，位于身体内衬和外罩之间的吸收体以及外壳。 外壳包括连接在一起的盖和背衬，以形成其中布置有物体的口袋。 外壳与吸收制品相连，适于从封闭状态转变到开放状态，使得设置在外壳内的物体可被访问。
-
公开(公告)号：US20220023322A1
公开(公告)日：2022-01-27
申请号：US17496814
申请日：2021-10-08
Applicant: Kimberly-Clark Worldwide, Inc.
Inventor： Jingru Li , Lindsay Adrienne Peed , Cheryce Francina Joyner , Rebecca Ann Vongsa , David William Koenig , Ryan Daniel Bartell , Paige Nicole Hollmaier
IPC: A61K31/7004 , A61K31/194 , A61K31/7016 , A61K31/724 , A61K31/70 , A61P15/02 , A61K9/00
Abstract: The present invention relates to compositions, particularly compositions useful in maintaining and supporting healthy microflora in the female urogenital tract which could lead to inhibition of vaginal infections, as well as methods of treating and preventing vaginal infections. Compositions useful in supporting healthy microflora, disclosed herein, generally comprise a therapeutic amount of a first saccharide and a therapeutic amount of a second saccharide or an organic acid. The saccharides may be, for example, a pentose, a disaccharide, a cyclodextrin, a pectic substance or a non-digestible polysaccharide. The organic acid may be, for example, malic acid.
-
公开(公告)号：US10717946B2
公开(公告)日：2020-07-21
申请号：US14655351
申请日：2012-12-27
Applicant: KIMBERLY-CLARK WORLDWIDE, INC. , David William Koenig , Mary Kay Foegen , Corey Thomas Cunningham , Aimin He , Yang Huang
Inventor： David William Koenig , Mary Kay Foegen , Corey Thomas Cunningham , Aimin He , Yang Huang
IPC: C11C3/00 , A61F13/84 , A01N65/00 , A01N65/12 , A01N65/22 , A01N65/48 , A01N65/36 , A01N65/28 , A01N25/34
Abstract: Methods for adjusting the solubility of a botanical oil in water, along with the resulting modified botanical oil and related products (e.g., treatment compositions, wipes, absorbent articles, etc.) are provided. In one embodiment, the method includes reacting the botanical oil to form a reactive product (e.g., having a hydroxyl group); and attaching a hydrophilic end group (e.g., a carboxylic acid, a carboxylic acid salt, a sugar, etc.) on the reactive product to form a modified botanical oil. The modified botanical oil generally, in most embodiments, has a greater solubility in water than the botanical oil (e.g., a solubility in water of about 10 grams per 100 grams of water or greater, such as completely soluble in water). The botanical oil includes, in one particular embodiment, an essential oil, such as those essential oil that include at least one terpene compound.
-
-
-
-
-
-
-
-
-
Search Results
27
records
(took 0.019 seconds)
